Merck & Co., Inc. (NYSE:MRK) Given New $113.00 Price Target at Morgan Stanley

Merck & Co., Inc. (NYSE:MRK – Get Free Report) had its price objective cut by equities research analysts at Morgan Stanley from $123.00 to $113.00 in a research note issued on Tuesday,Benzinga reports. The firm presently has an “equal weight” rating on the stock. Morgan Stanley’s target price would indicate a potential upside of 17.29% […]

Leave a Reply

Your email address will not be published.

Previous post Vistra (NYSE:VST) Coverage Initiated by Analysts at Evercore ISI
Next post Ballentine Partners LLC Has $5.10 Million Position in The Coca-Cola Company (NYSE:KO)